. Clinical Efficacy, Drug Safety, and Surrogate Endpoints: Has Aducanumab Met All of Its Expectations?. Neurology. 2021 Sep 14;97(11):517-518. Epub 2021 Jul 7 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Target or Decoy: Are Drug Developers Chasing the Right Thing?